AAV Cellular Immunogenicity: Capsid Reactivity vs. Transgene-Specific Immune Responses

In recombinant adeno-associated virus (rAAV) gene therapy development, neutralizing antibodies (NAbs) represent only one facet of vector-directed immunity. Host cytotoxic T lymphocytes (CTLs) and helper T cells frequently pose a severe obstacle to long-term transgene expression and patient safety. Following vector transduction, intracellular degradation of the viral capsid yields capsid-derived peptides that are presented via MHC Class I molecules on transduced host cells (e.g., hepatocytes, myocytes, CNS neurons). Memory CD8+ T cells recognize these complexes and trigger targeted cytotoxic lysis of transduced target cells, causing therapeutic transgene loss and transient transaminitis (liver enzyme flares).

Simultaneously, the therapeutic transgene product itself (e.g., human clotting factors, micro-dystrophin, lysosomal enzymes, or CRISPR gene-editing machinery like Cas9) represents a foreign neoantigen in null-mutation disease models, triggering de novo CD4+ and CD8+ T-cell expansion. Enzyme-Linked ImmunoSpot (ELISpot) is the gold-standard bioanalytical method to resolve and differentiate pre-existing memory against the AAV capsid from de novo cellular immunity directed against the transgene product.

Key Strengths of ELISpot for AAV Vector Immunogenicity Assessment

  • Differentiating Capsid vs. Transgene Immunity: Separate overlapping peptide libraries mapped to the viral capsid (VP1/VP2/VP3) and transgene sequence allow precise deconvolution of anti-vector versus anti-transgene T-cell responses.
  • Unrivaled Frequency Sensitivity (1 in 100,000+): Detects low-frequency memory T-cell clones (1–5 SFU per 10^6 PBMCs) that fall far below the detection limits of flow cytometric intracellular cytokine staining (ICS).
  • Cross-Serotype Reactivity Profiling: Enables parallel screening across natural serotypes (AAV2, AAV5, AAV8, AAV9) and novel synthetic or capsid-shuffled variants to guide serotype selection.
  • Dual IFN-γ / IL-2 FluoroSpot Option: Resolves effector/cytolytic memory (IFN-γ) from central proliferative memory (IL-2) at single-cell resolution.